ABT

Abbott Laboratories $101.95 1M -8.1% 3M +13.7% YTD -17.9% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.3%
Next 1 week
+0.5%
Next 1 month
+0.1%
Seasonality
Bullish window historically
Next 30 days (to Oct 13): +1.5% median, 60% of the last 45 years finished up.
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 1
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.09%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.04 +0.0% · Seasonal tilt +0.1%
$176.8B market cap (#50 US) $879M/day volume 27% volatility -21% 1-year -28% from ATH
52-week range · 36% of the way up · -26% from the high
$81.97$137.49

Congressional trades in ABT Full tracker →

52 members · 80 buys / 67 sells · $958K–$3.9M disclosed · latest filing Aug 18, 2026.

SELL RA Richard W. Allen · traded Jul 14, 2026 $15K–$50K
SELL RM Richard Dean McCormick · traded Jul 30, 2026 $1K–$15K
SELL MK Mike Kelly · traded Jul 17, 2026 $1K–$15K
SELL AA Alan Armstrong · traded Mar 27, 2026 $15K–$50K
SELL RL Rick Larsen · traded Jul 8, 2026 $1K–$15K
BUY RM Richard Dean McCormick · traded Jun 12, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Jun 16, 2026 $1K–$15K
SELL JJ Julie Johnson · traded May 12, 2026 $1K–$15K

Earnings Full history →

Next report 2026-10-14 (Wednesday, before open, in 31 days) · EPS est. 1.42.

1-day std dev
3.9%
Finished up
48%
Biggest pop
+10.7%
Biggest drop
-10.0%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.